SISI vs. BIOL, LIPO, MYMD, GNPX, LFLY, PCSA, ZVSA, GBNHF, IONM, and THAR
Should you be buying Shineco stock or one of its competitors? The main competitors of Shineco include BIOLASE (BIOL), Lipella Pharmaceuticals (LIPO), MyMD Pharmaceuticals (MYMD), Genprex (GNPX), Leafly (LFLY), Processa Pharmaceuticals (PCSA), ZyVersa Therapeutics (ZVSA), Greenbrook TMS (GBNHF), Assure (IONM), and Tharimmune (THAR). These companies are all part of the "medical" sector.
BIOLASE (NASDAQ:BIOL) and Shineco (NASDAQ:SISI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, community ranking, dividends, risk and profitability.
BIOLASE has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Shineco has a beta of -0.17, meaning that its share price is 117% less volatile than the S&P 500.
BIOLASE received 288 more outperform votes than Shineco when rated by MarketBeat users.
BIOLASE presently has a consensus target price of $77.00, indicating a potential upside of 53,003.45%. Given Shineco's higher probable upside, equities research analysts plainly believe BIOLASE is more favorable than Shineco.
Shineco has a net margin of 0.00% compared to Shineco's net margin of -41.97%. BIOLASE's return on equity of -32.33% beat Shineco's return on equity.
Shineco has lower revenue, but higher earnings than BIOLASE.
In the previous week, BIOLASE had 1 more articles in the media than Shineco. MarketBeat recorded 1 mentions for BIOLASE and 0 mentions for Shineco. Shineco's average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score.
8.8% of BIOLASE shares are held by institutional investors. Comparatively, 4.1% of Shineco shares are held by institutional investors. 0.3% of BIOLASE shares are held by company insiders. Comparatively, 0.3% of Shineco shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
BIOLASE beats Shineco on 7 of the 12 factors compared between the two stocks.
Get Shineco News Delivered to You Automatically
Sign up to receive the latest news and ratings for SISI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SISI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
